Skip to main content

Mothers May Be Key Source of LOD Strep in Neonates


Mothers appear to be the source of most neonatal group BStreptococcus (GBS) late-onset disease (LOD) infections, according to a the results of a prospective cohort study. In addition, preterm neonates have a high rate (1.4/1000 births) of group B Streptococcus (GBS) late-onset disease (LOD). They also carry the highest rate of mortality. Intrapartum antibiotics are associated with milder LOD (mild vs severe; P = .03) and delayed presentation of symptoms.
Alberto Berardi, MD, from the Azienda Ospedaliero-Universitaria Proclinico in Moddena, Italy, and colleagues published the results of their online January 7 in Pediatrics. They evaluated GBS-LOD infections during an 8-year period between 2003 and 2010. The study included a high percentage of preterm newborns.
LOD primarily presented as sepsis, meningitis, and/or focal infection. The investigators found that the earlier the presentation of LOD, the higher the risk for meningitis and death.
Approximately 50% of the preterm infants who were diagnosed with LOD were diagnosed as inpatients. This population had lower birth weight, younger gestational age, and more severe disease.
The rate of GBS-LOD in full term neonates was 0.24 per 1000 live births.
At the time of neonatal diagnosis, the authors found that most mothers (64%) carried GBS and some (6%) had mastitis.
Previous case reports have suggested that infected breast milk (even in the absence of mastitis) may be a cause of LOD. The authors also identified GBS-infected milk as a source of infection, noting that in some cases the milk was infected even if the mother did not have mastitis. The authors point out, however, that bacterial counts of milk cultures were not routinely available for mothers without mastitis.
One third of mothers who were screened antenatally and at the time of LOD diagnosis were culture-negative. More than half of women who were identified by screening as GBS-positive received antibiotics, and yet many women went on to transmit the organism to their infants.
Lately, there have been few reports of GBS outbreaks. The authors, however, note that population-based reports on GBS vary a great deal. Most studies agree that low birth weight is associated with an increased risk for GBS infection. Few studies, however, have included a significant number of preterm neonates.
The research leading to these results received funding from the European Community’s Seventh Framework Programme. This study was also supported by the Italian Ministry of Health. The authors have disclosed no relevant financial relationships.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more